US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist
  • 25.230
  • +1.130+4.69%
Trading Apr 23 10:35 ET
2.08BMarket Cap-14668P/E (TTM)

About Beam Therapeutics Company

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.

Company Profile

SymbolBEAM
Company NameBeam Therapeutics
Listing DateFeb 6, 2020
Issue Price17.00
Founded2017
CEOMr. John Evans
MarketNASDAQ
Employees436
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address238 Main Street,9th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142-1016
Phone1-857-327-8775

Company Executives

  • Name
  • Position
  • Salary
  • John Evans
  • Chief Executive Officer and Director
  • 6.28M
  • Dr. Christine Bellon, PhD
  • Chief Legal Officer and Secretary
  • 2.28M
  • Terry-Ann Burrell
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 2.56M
  • Dr. Amy Simon, M.D.
  • Chief Medical Officer
  • 2.55M
  • Dr. Giuseppe Ciaramella, PhD
  • President
  • 2.79M
  • Kathleen E. Walsh
  • Independent Director
  • 447.72K
  • Dr. Mark C. Fishman, M.D.
  • Lead Independent Director
  • 465.22K
  • Graham K. Cooper
  • Independent Director
  • 450.22K
  • Dr. John M. Maraganore,PhD
  • Independent Director
  • 435.22K
  • Kristina M. Burow
  • Independent Director
  • 445.22K
  • Christi Shaw
  • Independent Director
  • 772.68K
  • Dr. Carole Ho, M.D.
  • Independent Director
  • 442.72K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg